Page 31 - Reason Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reason Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reason Research Today - Breaking & Trending Today

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

Published: March 25, 2024

LOS ALTOS, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that multiple presentations will be delivered on the Company’s product candidates, oxylanthanum carbonate (OLC) and UNI-494, at the 61st European Renal Association (ERA) Congress taking place May 23-26, 2024, in Stockholm, Sweden. Shalabh Gupta, MD, Chief Execu

Source: yahoo.com

Unicycive Therapeutics to Present Two Posters on

Published: February 14, 2024

New Data to be Presented on the Bioequivalence Study for OLC...

Source: globenewswire.com

Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting - Unicycive Therapeutics (NASDAQ:UNCY)

Published: February 14, 2024

LOS ALTOS, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the "Company or

Source: benzinga.com

Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis

Published: December 18, 2023

LOS ALTOS, Calif., Dec. 18, 2023 -- Unicycive Therapeutics, Inc. , a clinical-stage biotechnology company developing therapies for patients with kidney disease , today announced the enrollment of...

Source: marketscreener.com

Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)

Published: October 23, 2023

- Pivotal clinical trial expected to initiate before year end - LOS ALTOS, Calif., Oct. 23, 2023 -- Unicycive Therapeutics, Inc. , a clinical-stage biotechnology company developing therapies...

Source: marketscreener.com